A Pilot Study of Mood in Epilepsy Patients Treated with Vagus Nerve Stimulation

Epilepsy and Behavior

Volumn 1, Issue 2, 2000, Pages 93-99

  Harden, Cynthia L ^a   Pulver, Melissa C ^a   Ravdin, Lisa D ^a   Nikolov, Blagovest ^a   Halper, James P ^a   Labar, Douglas R ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Vagus nerve stimulation; dysthymia; mood; epilepsy; depression

Indexed keywords

EID: 0002144698     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1006/ebeh.2000.0046     Document Type: Article

References (28)

1. Post R M, Ketter T A, Denicoff K. The place of anticonvulsant therapy in bipolar illness. Psychopharmacology. 128:1996;115-129.
2. Cullen M, Mitchell P, Brodaty H. Carbamazepine for treatment-resistant melancholia. J Clin Psychiatry. 52:1991;472-476.
3. Bowden C L, Brugger A M, Swann A C. Efficacy of divalproex versus lithium and placebo in the treatment of mania. JAMA. 271:1994;918-924.
4. McElroy S I, Soutullo C A, Keck P E, Kmetz G F. A pilot trial of adjunctive gabapentin in the treatment of bipolar disorder. Clin Psychiatry. 9:1997;99-103.
5. Schaffer C B, Schaffer L C. Gabapentin for the treatment of bipolar disorder. Am J Psychiatry. 154:1997;291.
6. Knoll J, Stegman K, Suppes T. Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania. J Affect Disord. 49:1998;229-233.
7. Ghaemi S N, Katzow J J, Desai S P, Goodwin F K. Gabapentin treatment of mood disorders: a preliminary study. J Clin Psychiatry. 59:1998;426-429.
8. Calabrese J R, Bowden C L, Sachs G S, Ascher J A, Monaghan E, Rudd G D. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry. 60:1999;79-88.
9. Calabrese J R, Bowden C L, McElroy S L, Coodson J, Andersen J, Keck P E Jr, Rhodes L, Bolden-Watson C, Zhou J, Ascher J A. Spectrum of activity in lamotrigine in treatment-refractory bipolar disorder. Am J Psychiatry. 156:1999;1019-1023.
10. Post R M, Weiss S R. A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures. Mol Neurobiol. 13:1996;33-60.
11. Robertson M M, Channon S, Baker J. Depressive symptomatology in a general hospital sample of outpatients with temporal lobe epilepsy: a controlled study. Epilepsia. 4:1994;771-777.
12. Blumer D, Montouris G, Hermann B. Psychiatric morbidity in seizure patients on a neurodiagnostic monitoring unit. J Neuropsychiatry Clin Neurosci. 7:1995;445-456.
13. Harden, C, L, Lazar, L, M, Pick, L, H, Nikolov, B, Goldstein, M, A, Carson, D, Ravdin, L, D, Kocsis, J, H, Labar, D, R, A beneficial effect on mood in partial epilepsy patients treated with gabapentin, Epilepsia, in press.
14. Neurology. 45:1995;224-230.
15. Rawlins P. Are there benefits, in addition to improved seizure control, for children receiving vagus nerve stimulation? Epilepsia. 38:1997;155-156.
16. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 12:1960;371-379.
17. Mason B, Kocsis J, Leon A. Measurement of severity and treatment response in dysthymia. Psychiatr Ann. 23:1993;625-631.
18. Beck A T. Depression: clinical, experimental, and theoretical aspects. 1967;Hoeber, New York.
19. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 32:1959;50-55.
20. Handforth A, DeGiorgio C M, Schachter S C, Uthman B M, Naritoku D K, Tecoma E S. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology. 51:1998;48-55.
21. Krahl S E, Clark K B, Smith D C, Browning R A. Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia. 39:1998;709-714.
22. Bunney W E, Davis J M. Norepinephrine in depressive reactions. Arch Gen Psychiatry. 13:1965;483-494.
23. Schatzberg A F, Schildkraut J J. Recent studies on norepinephrine systems in mood disorders. Bloom F, Kupfer D. Psychopharmacology: 4th generation of progress. 1996;911-920 Raven Press, New York.
24. Schachter S C, Saper C B. Vagus Nerve Stimulation. Epilepsia. 39:1998;677-686.
25. Maes M, Meltzer H Y. Serotonin hypothesis. Bloom F, Kupfer D. Psychopharmacology: 4th generations of progress. 1996;933-945 Raven Press, New York.
26. Ben-Menachem E, Hamberger A, Hedner T, Hammond E J, Uthman B M, Slater J, Treig T, Stefan H, Ramsay R E, Wernicke J F, Wilder B J. Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures. Epilepsy Res. 20:1995;221-227.
27. Hammond E J, Uthman B M, Wilder B J, Ben-Menachem E, Hamberger A, Hedner T, Ekman R. Neurochemical effects of vagus nerve stimulation in humans. Brain Res. 583:1992;300-303.
28. Sackeim H A, Luber B, Katzman G P, Moeller J R, Prudic J, Devanand D P, Nobler M S. The effects of electroconvulsive therapy on quantitative electroencephalograms: relationship to clinical outcome. Arch Gen Psychiatry. 53:1996;814-824.